tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX

Vertex Pharmaceuticals (VRTX) Revenue

Compare
6,620 Followers

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had a revenue of 3.23B in the quarter ending Dec 31, 2025, with 4.90%. This bring the company's revenue in the last twelve months to 12.04B, Decreased 2.69%. In the fiscal year ending Dec 31, 2025, Vertex Pharmaceuticals had annual revenue of 12.07B with 9.57% growth.
Revenue (ttm)
12.04B
Revenue Growth
10.53%
P/S Ratio
10.45
Revenue/Employee
$1,979,443
Employees
6,100
Market Cap
$126.21B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
12.07B1.05B+9.57%
Dec 31, 2024
11.02B1.15B+11.66%
Dec 31, 2023
9.87B938.50M+10.51%
Dec 31, 2022
8.93B1.36B+17.91%
Dec 31, 2021
7.57B1.37B+22.06%
Dec 31, 2020
6.21B2.04B+49.07%
Dec 31, 2019
4.16B1.12B+36.59%
Dec 31, 2018
3.05B558.95M+22.46%
Dec 31, 2017
2.49B